AstraZeneca and MedImmune, its global biologics research and development arm, will present updates from its respiratory medicines and pipeline at...
A pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat moderate-to-severe atopic dermatitis in adolescents (ages 12-17) met its primary...
Pfizer Inc. announced positive top-line results of a Phase 3 study examining the use of LYRICA® (pregabalin) Oral Solution CV...
ICON plc , a global provider of drug development and commercialisation solutions and services, announced that PMG Research, Inc., part...
Alnylam Pharmaceuticals, Inc , the leading RNAi therapeutics company, announced the appointment of a veteran healthcare leader, Colleen Reitan, to...
Grifols , a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, announced...
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the first positive Phase 1 clinical data assessing cemiplimab as a potential treatment...
Pharma major Lupin announced the successful completion of an inspection carried out by the US FDA at its Nagpur facility....
Kite, a Gilead Company announced it has leased a new facility in the Netherlands to engineer cell therapies in Europe....
Gilead Sciences, Inc. announced that the U.S. FDA has approved once-daily oral Truvada® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)—in...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
